Skip to main content
Table of Contents
Print

Does Cannabis for Sleep Apnoea Worsen Sleep Quality Over Time? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Using cannabis for sleep quality in patients with sleep apnoea  requires monitoring for potential long-term effects. While cannabinoids may initially improve sleep, their impact over time must be considered. 

Long-Term Effects of Cannabis 

Chronic use of cannabis for sleep quality can sometimes lead to diminishing benefits and unintended sleep disturbances. Evaluating long-term cannabis for sleep helps determine whether ongoing use supports or hinders restful sleep. 

Initial Sleep Improvement 

Cannabis for sleep quality may enhance sleep onset and duration in the short term. Many patients experience easier sleep initiation and reduced awakenings. 

Tolerance Development 

With long-term cannabis for sleep, tolerance can develop, potentially reducing effectiveness and contributing to disrupted sleep patterns. 

Sleep Disturbance Risk 

Sleep disturbance with cannabis may emerge with prolonged use, including fragmented sleep or changes in REM/NREM balance. Regular monitoring ensures therapy continues to support overall sleep health. 

Careful assessment of cannabis for sleep quality is essential for sleep apnoea patients. Awareness of long-term cannabis for sleep effects and sleep disturbance with cannabis allows patients and clinicians to optimise sleep management while minimising potential negative consequences. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories